Bioventus
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Bioventus's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0% to $512,345,000. The net income raised on -$156,230,000 and profit margin reached -30%. Total operating expenses were $409,918,000.

Profit Margin

Bioventus Inc. (NASDAQ:BVS): Profit margin
2013 232.37M -22.36M -9.63%
2014 242.89M -12.9M -5.31%
2015 253.65M -34.11M -13.45%
2017 292.05M -1.63M -0.56%
2018 319.17M -12.20M -3.82%
2019 340.14M 6.85M 2.01%
2020 321.16M 16.41M 5.11%
2021 430.89M 9.58M 2.22%
2022 512.11M -213.39M -41.67%
2023 512.34M -156.23M -30.49%

BVS Income Statement (2013 – 2023)

2023 2022 2021 2020 2019 2018 2017 2015 2014 2013
Revenue
Revenue
512.34M512.11M430.89M321.16M340.14M319.17M292.05M253.65M242.89M232.37M
Cost of revenue
184.15M181.03M128.19M87.64M90.93M84.16M92.09M74.34M74.60M71.37M
Gross profit
328.19M331.08M302.70M233.51M249.20M235.00M199.96M179.30M168.28M161.00M
Operating exp.
Research and development
13.44M25.94M19.03M11.20M11.05M8.09M8.09M14.74M9.46M10.93M
Selling and marketing
3.85M5.20M3.87M2.76M2.35M00000
Total operating expenses
409.91M379.7M281.65M211.71M217.43M207.64M172.93M173.75M165.49M169.07M
Operating income
-81.72M-35.67M17.72M21.23M31.19M25.50M27.02M-16.58M20K-8.06M
Other income (expenses), net
-39.38M-228.22M-10.10M-5.32M-21.50M-2.08M-18.36M-15.38M-11.37M-713K
Income before tax
-121.11M-263.89M7.62M15.91M9.68M6.10M8.65M-31.97M-11.35M-20.24M
Income tax expense
85K-50.50M-1.96M1.19M1.57M1.66M-785K2.14M1.54M2.12M
Net income
-156.23M-213.39M9.58M16.41M6.85M-12.20M-1.63M-34.11M-12.9M-22.36M
Earnings per share
Basic EPS
-2.49-3.480.160.07-0.01-0.22-0.02-0.61-0.23-0.4
Diluted EPS
-2.49-3.480.160.07-0.01-0.22-0.02-0.61-0.23-0.4
Data sourceData sourceData sourceData source